Valuation: Amedica Corporation

Market Cap 82.93L 72.61L 67.03L 62.6L 1.18Cr 78Cr 1.21Cr 8.07Cr 3.11Cr 39Cr 3.11Cr 3.05Cr 134.29Cr P/E 2026 *
-0.9x
P/E 2027 * -1.34x
Enterprise Value 82.93L 72.61L 67.03L 62.6L 1.18Cr 78Cr 1.21Cr 8.07Cr 3.11Cr 39Cr 3.11Cr 3.05Cr 134.29Cr EV / Sales 2026 *
3.6x
EV / Sales 2027 * 1.57x
Free-Float
65.08%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 82.93L
-0.10%+9.17%-15.93%+10.22% 13TCr
+0.44%+2.69%+2.74%-8.23% 1.28TCr
-1.24%+9.15%+38.64%+102.23% 847.83Cr
+3.27%-3.35%-48.73%-72.12% 378.86Cr
+2.94%+1.94%+21.28%+39.81% 251.54Cr
+6.68%+11.48%+238.24%+166.10% 155.28Cr
+20.00%+4.10%-11.29%-12.29% 153.09Cr
+4.97%+1.32%+3.29%-19.66% 152.91Cr
Average +3.23%+4.20%+28.53%+25.76% 2TCr
Weighted average by Cap. +0.29%+7.22%-9.03%+13.16%

Financials

2026 *2027 *
Net sales 23.04L 20.17L 18.62L 17.39L 32.73L 22Cr 33.48L 2.24Cr 86.5L 11Cr 86.51L 84.61L 37Cr 52.67L 46.12L 42.58L 39.76L 74.85L 50Cr 76.55L 5.12Cr 1.98Cr 25Cr 1.98Cr 1.93Cr 85Cr
Net income -1.24Cr -1.08Cr -1Cr -93.44L -1.76Cr -117.03Cr -1.8Cr -12Cr -4.65Cr -58Cr -4.65Cr -4.55Cr -200.45Cr -1.14Cr -99.61L -91.96L -85.87L -1.62Cr -107.56Cr -1.65Cr -11Cr -4.27Cr -53Cr -4.27Cr -4.18Cr -184.23Cr
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-